Roche, AbbVie leukemia drug superior to older medicine in study

(Reuters) - Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without the disease worsening than those treated with Rituxan and Treanda, according to interim results from a pivotal late stage study released on Tuesday.

Source: Reuters: Health - November 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news